Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center
Koichi Takeda(Japanese Foundation For Cancer Research), Daisuke Ohkushi(Japanese Foundation For Cancer Research), Koh Okamoto(Rush University Medical Center), Taisuke Enokida(Japanese Foundation For Cancer Research), Kenji Nakano(The Cancer Institute Hospital), Kosuke Hoashi(Aso Iizuka Hospital), Sohei Harada(University of Tokyo Hospital), Toshiharu Sasaki(Fujita Health University Hospital), Brian Hayama(Japanese Foundation For Cancer Research)
Cited by 28
Related Papers
Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study
|Mycoses|2019|80
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study
|Cancer Science|2021|72
High frequency of neurolymphomatosis as a relapse disease of intravascular large B‐cell lymphoma
|Cancer|2011|47
Comparison of the clinical risk factors between Candida albicans and Candida non-albicans species for bloodstream infection
|The Journal of Antibiotics|2014|26